SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement
SEC Accession No. 0001193125-10-117685
Filing Date
2010-05-12
Accepted
2010-05-12 17:25:07
Documents
3
Filing Date Changed
2010-05-12

Document Format Files

Seq Description Document Type Size
1 POST-EFFECTIVE AMENDMENT NO. 2 TO FORM S-1 dposam.htm POS AM 933171
2 OPINION OF COUNSEL AS TO THE LEGALITY OF THE SECURITIES BEING REGISTERED. dex51.htm EX-5.1 6018
3 CONSENT OF STONEFIELD JOSEPHSON, INC. dex231.htm EX-23.1 2072
  Complete submission text file 0001193125-10-117685.txt   942982
Mailing Address 21900 BURBANK BLVD. 3RD FLOOR WOODLAND HILLS CA 91367
Business Address 21900 BURBANK BLVD. 3RD FLOOR WOODLAND HILLS CA 91367 818-992-2907
ImmunoCellular Therapeutics, Ltd. (Filer) CIK: 0000822411 (see all company filings)

IRS No.: 931301885 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-150277 | Film No.: 10825387
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1